Literature DB >> 14591459

A validation of multiple malingering detection methods in a large clinical sample.

John E Meyers1, Marie E Volbrecht.   

Abstract

The purpose of this study is to further previous research that has shown that common neuropsychological tests can do "double duty" as test of motivation/malingering. Using a large clinical sample of 796 participants, it was found that the nine neuropsychological tests (when used together) were able to correctly identify litigant and nonlitigating groups. Failure on any two of the malingering tests suggested motivational/malingering issues. The groups consisted of mild, moderate, and severe traumatic brain-injured patients; chronic pain, depressed, community controls, and "malingering actors." Institutionalized and noninstitutionalized patient performance were also examined. This method showed 83% sensitivity and 100% specificity. A 0% false positive rate was found, suggesting good reliability especially in litigating settings. A group of patients for whom this method of motivational assessment might not be appropriate was also identified.

Entities:  

Mesh:

Year:  2003        PMID: 14591459

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  3 in total

Review 1.  Test validity and performance validity: considerations in providing a framework for development of an ability-focused neuropsychological test battery.

Authors:  Glenn J Larrabee
Journal:  Arch Clin Neuropsychol       Date:  2014-10-03       Impact factor: 2.813

2.  The dangers of failing one or more performance validity tests in individuals claiming mild traumatic brain injury-related postconcussive symptoms.

Authors:  Daniel A Proto; Nicholas J Pastorek; Brian I Miller; Jennifer M Romesser; Anita H Sim; John F Linck
Journal:  Arch Clin Neuropsychol       Date:  2014-09-24       Impact factor: 2.813

3.  Benefits and challenges of using logistic regression to assess neuropsychological performance validity: Evidence from a simulation study.

Authors:  Alexander Weigard; Robert J Spencer
Journal:  Clin Neuropsychol       Date:  2022-01-10       Impact factor: 4.373

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.